{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:28:28Z","timestamp":1790638108380,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.atherosclerosis.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T04:31:50Z","timestamp":1506745910000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-2918","authenticated-orcid":false,"given":"Frank","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perle","family":"Totoson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Prigent-Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Tournier-Nappey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Demougeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib1","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jbspin.2014.01.014","article-title":"Endothelial dysfunction in joint disease","volume":"81","author":"Prati","year":"2014","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jbspin.2012.12.002","article-title":"Vascular effects of nonsteroidal antiinflammatory drugs","volume":"80","author":"Soubrier","year":"2013","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","article-title":"Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients","volume":"68","author":"Goodson","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.162.10.1105","article-title":"Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis","volume":"162","author":"Watson","year":"2002","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2012-203137","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","volume":"73","author":"Lindhardsen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/03009740701286771","article-title":"Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis","volume":"36","author":"Wong","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib11","doi-asserted-by":"crossref","first-page":"690596","DOI":"10.1155\/2014\/690596","article-title":"Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents","volume":"2014","author":"Kshirsagar","year":"2014","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10787-014-0200-5","article-title":"Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1","volume":"22","author":"El-Sayed","year":"2014","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib13","doi-asserted-by":"crossref","first-page":"e0146744","DOI":"10.1371\/journal.pone.0146744","article-title":"Endothelial dysfunction in rheumatoid arthritis: mechanistic insights and correlation with circulating markers of systemic inflammation","volume":"11","author":"Totoson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib14","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar3860","article-title":"Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis","volume":"14","author":"Prati","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/kew062","article-title":"Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis","volume":"55","author":"Totoson","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib16","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/art.30391","article-title":"Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway","volume":"63","author":"Prati","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar4450","article-title":"Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies","volume":"16","author":"Totoson","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.atherosclerosis.2008.06.008","article-title":"Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease","volume":"202","author":"Luksha","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/HYPERTENSIONAHA.111.00995","article-title":"Endothelial dysfunction in small arteries of essential hypertensive patients : role of Cyclooxygenase-2 in oxidative stress generation","volume":"62","author":"Virdis","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.HYP.0000164572.92049.29","article-title":"Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats","volume":"45","author":"Wu","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.intimp.2006.09.021","article-title":"Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion","volume":"7","author":"Talmadge","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4097\/kjae.2010.59.3.196","article-title":"Effect of ketorolac and diclofenac on the impairment of endothelium-dependent relaxation induced by reactive oxygen species in rabbit abdominal aorta","volume":"59","author":"Lee","year":"2010","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","article-title":"Diclofenac: an update on its mechanism of action and safety profile","volume":"26","author":"Gan","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib25","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00466.2009","article-title":"Thrombin induces endothelial arginase through AP-1 activation","volume":"298","author":"Zhu","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/ATVBAHA.108.163592","article-title":"AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit","volume":"28","author":"Manea","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib27","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1111\/bph.13242","article-title":"Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus","volume":"172","author":"Pernow","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/01.HYP.0000115921.55353.e0","article-title":"Effects of COX inhibition on blood pressure and kidney function in ACE-inhibitor treated blacks and hispanics","volume":"43","author":"Izhar","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib29","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.CIR.0000101683.30157.0B","article-title":"Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension","volume":"108","author":"Hermann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-5922.2011.00283.x","article-title":"Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs","volume":"30","author":"Krum","year":"2012","journal-title":"Cardiovasc Ther."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/FJC.0b013e3182010a96","article-title":"Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusion","volume":"57","author":"Robich","year":"2011","journal-title":"J.\u00a0Cardiovasc Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.108.139030","article-title":"Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases","volume":"326","author":"Li","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00210-010-0586-6","article-title":"Celecoxib induces heme-oxygenase-1 expression in macrophages and vascular smooth muscle cells via ROS-dependent signaling pathway","volume":"383","author":"Wang","year":"2011","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"issue":"131","key":"10.1016\/j.atherosclerosis.2017.09.033_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.114.011591","article-title":"Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs","volume":"17","author":"Ahmetaj-Shala","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prostaglandins.2006.05.019","article-title":"Pharmacodynamic of cyclo-oxygensae inhibitors in humans","volume":"82","author":"Capone","year":"2007","journal-title":"Prostagl. other lipid Mediat."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/0091270008317590","article-title":"Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects","volume":"48","author":"Schwartz","year":"2008","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fphys.2010.00145","article-title":"Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries","volume":"1","author":"Vessi\u00e8res","year":"2010","journal-title":"Front. Physiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib38","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.CIR.0000101683.30157.0B","article-title":"Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension","volume":"108","author":"Hermann","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.09.033_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1159\/000245060","article-title":"Role of cyclooxygenase and derived reactive oxygen species in rho-kinase-mediated impairment of endothelium-dependent vasodilation and blood flow after ischemia-reperfusion of the rat kidney","volume":"114","author":"Versteilen","year":"2010","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1759720X14541668","article-title":"Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs","volume":"6","author":"Fabule","year":"2014","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.23911","article-title":"Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups","volume":"59","author":"Solomon","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib43","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib44","first-page":"691","article-title":"Aldosterone glucuronidation inhibition as a potential mechanism for arterial dysfunction associated with chronic celecoxib and diclofenac use in patients with rheumatoid arthritis","volume":"31","author":"Crilly","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib45","doi-asserted-by":"crossref","first-page":"72B","DOI":"10.1016\/S0828-282X(06)70990-4","article-title":"Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk","volume":"22","author":"Anderson","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib46","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1097\/MD.0000000000004792","article-title":"Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: a nation-wide, population-based case-control study","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5152\/eurjrheum.2016.15096","article-title":"Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis","volume":"3","author":"\u015eent\u00fcrk","year":"2016","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00365513.2016.1177852","article-title":"In\u00a0vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort","volume":"76","author":"Dimitroulas","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib49","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.115.305278","article-title":"Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis","volume":"35","author":"Lambden","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.033_bib50","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1096\/fj.201600647R","article-title":"Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2\/ADMA axis","volume":"30","author":"Kirkby","year":"2016","journal-title":"FASEB J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T14:28:02Z","timestamp":1603031282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"alternative-id":["S0021915017313199"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.033","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}